|
|
||||||||
Clinical Investigation |
1 Department of Nuclear Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 2 Department of Urology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 3 Department of Diagnostic and Interventional Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; and 4 Department of Gynaecology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Correspondence: For correspondence or reprints contact: Ehab M. Kamel, MD, Nuclear Medicine, University Hospital, CH-1011 Lausanne, Switzerland. E-mail: Mohamed-Ehab.Kamel{at}chuv.ch
Our aim was to evaluate the role of forced diuresis in improving the diagnostic accuracy of abdominopelvic 18F-FDG PET. Methods: Thirty-two patients were enrolled. Besides the presence of known intravesical tumors or undefined renal lesions on the initial PET scan, the inclusion criterion was the appearance of indeterminate or equivocal 18F-FDG foci that extended along the course of the urinary tract and could not confidently be separated from urinary activity. For each patient, a second abdominopelvic PET study was performed after intravenous injection of 0.5 mg of furosemide per kilogram of body weight (maximum, 40 mg) coupled with parenteral infusion of physiologic saline. Results: Forced diuresis coupled with parenteral hydration eliminated any significant 18F-FDG activity from the lower urinary tract in 31 (97%) of 32 patients after the bladder had been voided 3 successive times. Twelve intravesical lesions were visualized with outstanding clarity, whereas radiologic suspicion of locally recurrent bladder tumors was ruled out in 3 patients. Among 14 indeterminate or equivocal extravesical foci, 7 were deemed of no clinical value because they disappeared after furosemide challenge, whereas 7 persisting foci were proven to be true-positive PET findings. The performance of 18F-FDG PET in characterizing 3 renal-spaceoccupying lesions could not be improved by our protocol. Conclusion: Furosemide challenge has the potential to noninvasively resolve the inherent 18F-FDG contrast handicap in the lower urinary tract.
Key Words: 18F-FDG PET/CT forced diuresis bladder cancer
Related articles in JNM:
This article has been cited by other articles:
![]() |
D. A. Anjos, E. C.S.C. Etchebehere, C. D. Ramos, A. O. Santos, C. Albertotti, and E. E. Camargo 18F-FDG PET/CT Delayed Images After Diuretic for Restaging Invasive Bladder Cancer J. Nucl. Med., May 1, 2007; 48(5): 764 - 770. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |